Melanie Doyle-Eisele, Ph.D., heads the Life Sciences division, which includes study directors and technical and necropsy staff. Dr. Doyle-Eisele has served as study director on over 250 studies, including GLP and non-GLP PK, ADME, safety/toxicity, efficacy and general toxicology/pharmacology studies using animal models ranging from rodents to NHPs. She has expertise in pharmaceutical development applied both to traditional pathways (IND/NDA) and animal rule work performed for development of medical countermeasures. Dr. Doyle-Eisele received a B.S. in chemistry from the University of South Carolina and a Ph.D. in inhalation toxicology and environmental chemistry from the University of North Carolina. Dr. Doyle-Eisele joined Lovelace in 2007.